Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nontemplated nucleotide addition by HIV-1 reverse transcriptase.

Marie-Pierre Golinelli1, Stephen H Hughes

  • 1HIV Drug Resistance Program, National Cancer Institute at Frederick, P.O. Box B, Building 539, Room 130A, Frederick, Maryland 21702-1201, USA.

Biochemistry
|May 1, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV-1 uncoating location dictates sites of integration.

Nature communications·2026
Same author

Comparative Analyses of Antiviral Potencies of Second-Generation Integrase Strand Transfer Inhibitors (INSTIs) and the Developmental Compound 4d Against a Panel of Integrase Quadruple Mutants.

Viruses·2025
Same author

HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer.

mBio·2024
Same author

<i>N</i>-Substituted Bicyclic Carbamoyl Pyridones: Integrase Strand Transfer Inhibitors that Potently Inhibit Drug-Resistant HIV-1 Integrase Mutants.

ACS infectious diseases·2024
Same author

The largest HIV-1-infected T cell clones in children on long-term combination antiretroviral therapy contain solo LTRs.

mBio·2023
Same author

Mechanisms of HIV-1 integrase resistance to dolutegravir and potent inhibition of drug-resistant variants.

Science advances·2023

Nontemplated nucleotide addition by HIV-1 reverse transcriptase is inefficient in vivo. Factors like dNTP binding, ATP competition, and lack of stable complexes limit this process, making it much slower than templated polymerization.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Virology

Background:

  • Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) plays a crucial role in viral replication.
  • Nontemplated nucleotide addition is a known but poorly understood activity of RT.

Purpose of the Study:

  • To investigate the kinetics and factors influencing nontemplated nucleotide addition by HIV-1 RT.
  • To compare the efficiency of nontemplated versus templated nucleotide polymerization.

Main Methods:

  • Utilized model substrates derived from the 3' end of HIV-1 minus-strand strong-stop DNA.
  • Analyzed reaction kinetics under varying conditions (pH, salt, nucleoside type, duplex structure).
  • Employed gel retardation assays to detect ternary complex formation (RT/DNA/dNTP).

Related Experiment Videos

Main Results:

  • Nontemplated nucleotide addition is highly dependent on base identity, nucleoside type, and pH.
  • Efficiency is significantly influenced by the 3' end sequence of the DNA duplex.
  • Nontemplated addition is at least 1000-fold slower than templated polymerization, with K(d) values 1000-fold higher for blunt-ended duplexes.
  • ATP competes with dNTPs, reducing nontemplated addition efficiency.
  • Stable ternary complexes were not observed with blunt-ended duplexes, unlike those with template overhangs.
  • In vivo conditions (low dNTPs, high ATP) further decrease nontemplated addition efficiency.

Conclusions:

  • Nontemplated nucleotide addition by HIV-1 RT is a highly inefficient process in vivo.
  • Unfavorable dNTP binding, ATP competition, and the inability to form stable ternary complexes limit this activity.
  • These factors collectively ensure that templated polymerization remains the dominant and efficient mode of DNA synthesis by HIV-1 RT.